PES1 differentially regulates the expression of ERα and ERβ in ovarian cancer

IUBMB Life

Volumn 65, Issue 12, 2013, Pages 1017-1025

  Li, Jieping ^a   Zhuang, Qinren ^a   Lan, Xiaopeng ^b   Zeng, Guobin ^a   Jiang, Xuping ^a   Huang, Zongming ^a  

^a General Hospital of Fujian Corps of CAPF   (China)

^b FUZHOU GENERAL HOSPITAL   (China)

Author keywords

estrogen receptor alpha; estrogen receptor beta; ovarian cancer; pescadillo PES1; transcriptional activity

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE INHIBITOR 1; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PES1 PROTEIN; PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PATIENT; CANCER TISSUE; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; OVARY CARCINOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; RECEPTOR DOWN REGULATION; UPREGULATION;

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; OVARIAN CANCER; PESCADILLO/PES1; TRANSCRIPTIONAL ACTIVITY;

CASE-CONTROL STUDIES; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; MCF-7 CELLS; OVARIAN NEOPLASMS; OVARY; PROTEINS; TRANSCRIPTION, GENETIC;

EID: 84891277799     PISSN: 15216543     EISSN: 15216551     Source Type: Journal    
DOI: 10.1002/iub.1228     Document Type: Article

References (56)

1. Lazannec, G., (2006) Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis. Cancer Lett. 231, 151-157.
2. Rosenfeld, C. S., Wagner, J. S., Roberts, R. M., and, Lubahn, D. B., (2001) Intraovarian actions of oestrogen. Reproduction 122, 215-226.
3. Li, Y. F., Hu, W., Fu, S.Q., Li, J.D., Liu, J. H., and, Kavanagh, J. J., (2008) Aromatase inhibitors in ovarian cancer: is there a role? Int. J. Gynecol. Cancer. 18, 600-614.
4. Bookman, M. A., (2005) Is there still a role for hormonal therapy? Int. J. Gynecol. Cancer 15, 291-297.
5. Zheng, H., Kavanagh, J. J., Hu, W., Liao, Q., and, Fu, S., (2007) Hormonal therapy in ovarian cancer. Int. J. Gynecol. Cancer 17, 325-338.
6. Auranen, A., Hietanen, S., Salmi, T., and, Grénman, S., (2005) Hormonal treatments and epithelial ovarian cancer risk. Int. J. Gynecol. Cancer 15, 692-700.
7. Klinge, C. M., (2000) Estrogen receptor interaction with co-activators and corepressors. Steroids 65, 227-251.
8. Aranda, A., and, Pascual, A., (2001) Nuclear hormone receptors and gene expression. Physiol. Rev. 81, 1269-1304.
9. Dobrzycka, K. M., Townson, S. M., Jiang, S., and, Oesterreich, S., (2003) Estrogen receptor co-repressors-a role in human breast cancer? Endocr. Relat. Cancer 10, 517-536.
10. Allende, M. L., Amsterdam, A., Becker, T., Kawakami, K., Gaiano, N., et al. (1996) Insertional mutagenesis in zebrafish identifies two novel genes, pescadillo and dead eye, essential for embryonic development. Genes. Dev. 10, 3141-3155.
11. Haque, J., Boger, S., Li, J., and, Duncan SA,. (2000) The murine Pes1 gene encodes a nuclear protein containing a BRCT domain. Genomics 70, 201-210.
12. Kinoshita, Y., Jarell, A. D., Flaman, J. M., Foltz, G., Schuster, J., et al. (2001) Pescadillo, a novel cell cycle regulatory protein abnormally expressed in malignant cells. J. Biol. Chem. 276, 6656-6665.
13. Koonin, E. V., Altschul, S. F., and, Bork, P., (1996) BRCA1 protein products. Functional motifs. Nat. Genet. 13, 266-268.
14. Bork, P., Hofmann, K., Bucher, P., Neuwald, A. F., Altschul, S. F., et al. (1997) A super-family of conserved domains in DNA damage-responsive cell cycle checkpoint proteins. FASEB. J. 11, 68-76.
15. Callebaut, I., and, Mornon, J. P., (1997) From BRCA1 to RAP1: a widespread BRCT module closely associated with DNA repair. FEBS. Lett. 400, 25-30.
16. Lerch-Gaggl, A., Haque, J., Li, J., Ning, G., Traktman, P., et al. (2002) Pescadillo is essential for nucleolar assembly, ribosome biogenesis, and mammalian cell proliferation. J. Biol. Chem. 277, 45347-45355.
17. Prisco, M., Maiorana, A., Guerzoni, C., Calin, G., Calabretta, B., et al. (2004) Role of pescadillo and upstream binding factor in the proliferation and differentiation of murine myeloid Cells. Mol. Cell. Biol. 24, 5421-5433.
18. Kim, B., Bang, S., Lee, S., Kim, S., Jung, Y., et al. (2003) Expression profiling and subtypespecific expression of stomach cancer. Cancer. Res. 63, 8248-8255.
19. Li, Y., Hong, X., Hussain, M., Sarkar, S. H., Li, R., and, Sarkar, F. H., (2005) Gene expression profiling revealed novel molecular targets of docetaxel and estramustine combination treatment in prostate cancer cells. Mol. Cancer. Ther. 4, 389-398.
20. Li, Y., and, Sarkar, F. H., (2002) Gene expression profiles of genistein-treated PC3 prostate cancer cells. J. Nutr. 132, 3623-3631.
21. Zhang, H., Li, J., Wang, X., Sun, Y., Yuan, B., et al. (2007) The antibody preparation and expression of human pescadillo. Sci. China. C. Life Sci. 50, 298-304.
22. Li, J., Yu, L., Zhang, H., Wu, J., Yuan, J., et al. (2009) Down-regulation of pescadillo inhibits proliferation and tumorigenicity of breast cancer cells. Cancer Sci. 100, 2255-2260.
23. Cheng, L., Li, J., Han, Y., Lin, J., Niu, C., et al. (2012) PES1 promotes breast cancer by differentially regulating ERα and ERβ. J. Clin. Invest. 122, 2857-2870.
24. Gessert, S., Maurus, D., Rössner, A., and, Kühl, M., (2007) Pescadillo is required for Xenopus laevis eye development and neural crest migration. Dev. Biol. 310, 99-112.
25. Xie, W., Feng, Q., Su, Y., Dong, B., Wu, J., et al. (2012) Transcriptional regulation of PES1 expression by c-Jun in colon cancer. PLoS. One. 7, e42253.
26. Maiorana, A., Tu, X., Cheng, G., and, Baserga, R., (2004) Role of pescadillo in the transformation and immortalization of mammalian cells. Oncogene 23, 7116-7124.
27. Sarker, K. P., Wilson, S. M., and, Bonni S,. (2005) SnoN is a cell type-specific mediator of transforming growth factor-beta responses. J. Biol. Chem. 280, 13037-13046.
28. Tynan, S. H., Lundeen, S. G., and, Allan, G. F., (2004) Cell type-specific bidirectional regulation of the glucocorticoid-induced leucine zipper (GILZ) gene by estrogen. J. Steroid Biochem. Mol. Biol. 91, 225-239.
29. Zhang, H., Wang, X., Li, J., Zhu, J., Xie, X., et al. (2007) Tissue type-specific modulation of ER transcriptional activity by NFAT3. Biochem. Biophys. Res. Commun. 353, 576-581.
30. Zhang, H., Xie, X., Zhu, X., Zhu, J., Hao, C., et al. (2005) Stimulatory cross-talk between NFAT3 and estrogen receptor in breast cancer cells. J. Biol. Chem. 280, 43188-43197.
31. Zhu, J., Hua, K., Sun, H., Yu, Y., Jin, H., et al. (2011) Re-expression of estrogen receptor β inhibits the proliferation and migration of ovarian clear cell adenocarcinoma cells. Oncol. Rep. 26, 1497-1503.
32. Welboren, W. J., Sweep, F. C., Span, P. N., and, Stunnenberg, H. G., (2009) Genomic actions of estrogen receptor α: what are the targets and how are they regulated? Endocr. Relat. Cancer 16, 1073-1089.
33. Williams, C., Edvardsson, K., Lewandowski, S. A., Strom, A., and, Gustafsson, J. A., (2008) A genome-wide study of the repressive effects of estrogen receptor β on estrogen receptor α signaling in breast cancer cells. Oncogene 27, 1019-1032.
34. Ho, Q. T., and, Kuo, C. J., (2007) Vascular endothelial growth factor: biology and therapeutic applications. Int. J. Biochem. Cell. Biol. 39, 1349-1357.
35. Thomas, C., and, Gustafsson, J. A., (2011) The different roles of ER subtypes in cancer biology and therapy. Nat. Rev. Cancer 11, 597-608.
36. Matthews, J., and, Gustafsson, J. A., (2003) Estrogen signaling: a subtle balance between ERα and ERβ. Mol. Interv. 3, 281-292.
37. Drummond, A. E., and, Fuller, P. J., (2010) The importance of ERbeta signalling in the ovary. J. Endocrinol. 205, 15-23.
38. Cunat, S., Hoffmann, P., and, Pujol, P., (2004) Estrogens and epithelial ovarian cancer. Gynecol. Oncol. 94, 25-32.
39. Lindgren, P. R., Cajander, S., Bäckström, T., Gustafsson, J. A., Mäkelä, S., et al. (2004) Estrogen and progesterone receptors in ovarian epithelial tumors. Mol. Cell. Endocrinol. 221, 97-104.
40. Chan, K. K., Wei, N., Liu, S. S., Xiao, Y. L., Cheung, A. N., et al. (2008) Estrogen receptor subtypes in ovarian cancer: a clinical correlation. Obstet. Gynecol. 111, 144-151.
41. Halon, A., Nowak-Markwitz, E., Maciejczyk, A., Pudelko, M., Gansukh, T., et al. (2011) Loss of estrogen receptor beta expression correlates with shorter overall survival and lack of clinical response to chemotherapy in ovarian cancer patients. Anticancer. Res. 31, 711-718.
42. Bossard, C., Busson, M., Vindrieux, D., Gaudin, F., Machelon, V., et al. (2012) Potential role of estrogen receptor beta as a tumor suppressor of epithelial ovarian cancer. PLoS. One. 7, e44787.
43. O'Donnell, A. J., Macleod, K. G., Burns, D. J., Smyth, J. F., and, Langdon, S. P., (2005) Estrogen receptor alpha mediates gene expression changes and growth response in ovarian cancer cells exposed to estrogen. Endocr. Relat. Cancer 12, 851-866.
44. Park, S. H., Cheung, L. W., Wong, A. S., and, Leung, P. C., (2008) Estrogen regulates Snail and Slug in the down-regulation of E-cadherin and induces metastatic potential of ovarian cancer cells through estrogen receptor alpha. Mol. Endocrinol. 22, 2085-2098.
45. Hua, K., Feng, W., Cao, Q., Zhou, X., Lu, X., et al. (2008) Estrogen and progestin regulate metastasis through the PI3K/AKT pathway in human ovarian cancer. Int. J. Oncol. 33, 959-967.
46. Charpentier, A. H., Bednarek, A. K., Daniel, R. L., Hawkins, K. A., Laflin, K. J., et al. (2000) Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer. Res. 60, 5977-5983.
47. Suzuki, F., Akahira, J., Miura, I., Suzuki, T., Ito, K., et al. (2008) Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5′-untranslated region in human epithelial ovarian carcinoma. Cancer Sci. 99, 2365-2372.
48. Yap, O. W., Bhat, G., Liu, L., and, Tollefsbol, T. O., (2009) Epigenetic modifications of the estrogen receptor beta gene in epithelial ovarian cancer cells. Anticancer Res. 29, 139-144.
49. Holst, F., Stahl, P. R., Ruiz, C., Hellwinkel, O., Jehan, Z., et al. (2007) Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer. Nat. Genet. 39, 655-660.
50. Issa, R. M., Lebeau, A., Grob, T., Holst, F., Moch, H., et al. (2009) Estrogen receptor gene amplification occurs rarely in ovarian cancer. Mod. Pathol. 22, 191-196.
51. Lapik, Y. R., Fernandes, C. J., Lau, L. F., and, Pestov, D. G., (2004) Physical and functional interaction between Pes1 and Bop1 in mammalian ribosome biogenesis. Mol. Cell. 15, 17-29.
52. Killian, A., Le, M. N., Sesboüé, R., Bourguignon, J., Bougeard, G., et al. (2004) Inactivation of the RRB1-Pescadillo pathway involved in ribosome biogenesis induces chromosomal instability. Oncogene 23, 8597-8602.
53. Grimm, T., Hölzel, M., Rohrmoser, M., Harasim, T., Malamoussi, A., et al. (2006) Dominant-negative Pes1 mutants inhibit ribosomal RNA processing and cell proliferation via incorporation into the PeBoW-complex. Nucleic Acids Res. 34, 3030-3043.
54. Nam, E. J., and, Kim, Y. T., (2008) Alteration of cell-cycle regulation in epithelial ovarian cancer. Int. J. Gynecol. Cancer 18, 1169-1182.
55. Musgrove, E. A., Caldon, C.E., Barraclough, J., Stone, A., and, Sutherland, R. L., (2011) Cyclin D as a therapeutic target in cancer. Nat. Rev. Cancer 11, 558-572.
56. Mueller, M. D., Vigne, J. L., Minchenko, A., Lebovic, D. I., Leitman, D. C., et al. (2000) Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta. Proc. Natl. Acad. Sci. USA 97, 10972-10977.